A detailed history of State Street Corp transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 3,098,806 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,098,806
Previous 2,470,813 25.42%
Holding current value
$0
Previous $39.9 Million 22.31%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.58 - $17.36 $8.53 Million - $10.9 Million
627,993 Added 25.42%
3,098,806 $48.7 Million
Q4 2023

Feb 14, 2024

BUY
$10.11 - $16.54 $1.61 Million - $2.64 Million
159,695 Added 6.91%
2,470,813 $39.9 Million
Q3 2023

Nov 14, 2023

SELL
$12.46 - $15.48 $10.7 Million - $13.3 Million
-858,377 Reduced 27.08%
2,311,118 $29.4 Million
Q2 2023

Aug 14, 2023

SELL
$13.28 - $15.96 $2.03 Million - $2.44 Million
-152,655 Reduced 4.6%
3,169,495 $44.6 Million
Q1 2023

May 15, 2023

SELL
$14.26 - $22.1 $1.79 Million - $2.78 Million
-125,874 Reduced 3.65%
3,322,150 $51.3 Million
Q4 2022

Feb 14, 2023

BUY
$14.85 - $19.04 $3.4 Million - $4.35 Million
228,693 Added 7.1%
3,448,024 $56.5 Million
Q3 2022

Nov 15, 2022

SELL
$12.38 - $20.23 $8.81 Million - $14.4 Million
-711,586 Reduced 18.1%
3,219,331 $59.6 Million
Q2 2022

Aug 15, 2022

SELL
$9.11 - $13.98 $16.5 Million - $25.3 Million
-1,807,853 Reduced 31.5%
3,930,917 $51.7 Million
Q1 2022

May 16, 2022

SELL
$6.87 - $11.11 $5.08 Million - $8.22 Million
-740,052 Reduced 11.42%
5,738,770 $53.2 Million
Q4 2021

Feb 14, 2022

BUY
$7.7 - $37.13 $35.1 Million - $169 Million
4,557,902 Added 237.28%
6,478,822 $63.3 Million
Q3 2021

Nov 15, 2021

SELL
$26.46 - $37.15 $3.44 Million - $4.83 Million
-129,914 Reduced 6.33%
1,920,920 $65.3 Million
Q2 2021

Aug 16, 2021

BUY
$32.73 - $47.95 $6.28 Million - $9.2 Million
191,797 Added 10.32%
2,050,834 $75.1 Million
Q1 2021

May 17, 2021

BUY
$40.39 - $56.73 $1.01 Million - $1.42 Million
24,962 Added 1.36%
1,859,037 $83.4 Million
Q4 2020

Feb 16, 2021

BUY
$51.77 - $66.18 $3.36 Million - $4.3 Million
64,913 Added 3.67%
1,834,075 $105 Million
Q3 2020

Nov 10, 2020

BUY
$43.8 - $58.16 $2.13 Million - $2.82 Million
48,524 Added 2.82%
1,769,162 $90.8 Million
Q2 2020

Aug 14, 2020

BUY
$37.05 - $65.03 $24.1 Million - $42.2 Million
649,251 Added 60.6%
1,720,638 $103 Million
Q1 2020

May 11, 2020

BUY
$33.63 - $69.4 $36 Million - $74.4 Million
1,071,387 New
1,071,387 $44.1 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.